Antoine Legras

Antoine Legras


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
ALAntoine Legras
Antoine Legras
MBMarc Barritault
Marc Barritault
ATAnne Tallet
Anne Tallet
EFElizabeth Fabre
Elizabeth Fabre
AGAlice Guyard
Alice Guyard
HBHélène Blons
Hélène Blons

30 April 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Xavier CansoulineXavier Cansouline
Xavier Cansouline
BLBéatrice Lipan
Béatrice Lipan
DSDamien Sizaret
Damien Sizaret
ATAnne Tallet
Anne Tallet
CVChristophe Vandier
Christophe Vandier
ALAntoine Legras
Antoine Legras
The ADAURA trial has been significant for the perception of EGFR tyrosine kinase inhibitors (TKIs) as a tool for early stage non-small-cell lung cancer (NSCLC). It produced such great insight that the main TKI, Osimertinib, was rapidly integrated into international guidelines for adjuvant use. However, EGFR-mutant NSCLC is a complex entity and has various targeting drugs, and the benefits for patients might not be as clear as they seem. We reviewed trials and meta-analyses considering TKI adjuvant and neoadjuvant use. We also explored the influence of mutation variability and financial evaluations. We found that TKIs often show disease-free survival (DFS) benefits, yet studies have struggled to improve the overall survival (OS); however, the results from the literature might be confusing because of variability in the stages and mutations. The safety profiles and adverse events are acceptable, but costs remain high and accessibility might not be optimal. TKIs are promising drugs that could allow for tailored treatment designs.

1 January 2023 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
MTMarin Théry
Marin Théry
ALAdrien LEMAIGNEN
Adrien LEMAIGNEN
TFThomas Flament
Thomas Flament
FRFrancis Remérand
Francis Remérand
QLQuentin Langouet
Quentin Langouet
ALAntoine Legras
Antoine Legras
Original Article Infectious morbi-mortality in thoracic surgery after major resections Marin Théry, Adrien Lemaignen, Thomas Flament, Francis Remérand, Quentin Langouet, Béatrice Lipan, Thierry Bourguignon, Antoine Legras

1 January 2022 in Journal of Surgery and Research
Verified
Journal Article
Open access
PDF file
JSJuliette Strella
Juliette Strella
QLQuentin Langouet
Quentin Langouet
EMEtienne Marchand
Etienne Marchand
JPJulien Pucheux
Julien Pucheux
ALAntoine Legras
Antoine Legras
RMRobert Martinez
Robert Martinez
A 58 years-old woman presented a rare right-sided aortic arch with an aberrant left subclavian retro-esophageal artery, originates from Kommerell’s diverticulum. After left subclavian to carotid transposition, we implanted a thoracic endoprosthesis under ventricular fibrillation. Type IA symptomatic proximal endoleak was treated with a second endograft a week later. We shared here technical aspects and challenges of endovascular management, including precise preoperative imaging (CT angiography, lymphangio-MRI), the need of a hybrid operative room, conformable endoprosthesis and right ventricle overstimulation.

1 December 2011 in Annales de Dermatologie et de Vénéréologie
Verified
Journal Article
Closed access
LLL. Lagier
L. Lagier
BCB. Chaigne
B. Chaigne
APA. Perrinaud
A. Perrinaud
ALAntoine Legras
Antoine Legras
GLG. Lorette
G. Lorette
LMLaurent Machet
Laurent Machet